Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucin-producing elements and inflammatory cells.

Peter Jeffery1, Jie Zhu

  • 1Lung Pathology, Department of Gene Therapy, Imperial College School of Medicine, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.

Novartis Foundation Symposium
|February 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protrusive waves guide 3D cell migration along nanofibers.

The Journal of cell biology·2015
Same author

Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding.

Acta crystallographica. Section D, Biological crystallography·2015
Same author

[Qibaipingfei Capsule down-regulate the levels of calcineurin and nuclear factor of activated T-cells isoform c3 (NFATc3) in chronic obstructive pulmonary disease].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2015
Same author

Short-Term Prognosis of Mechanically Ventilated Patients With Guillain-Barré Syndrome Is Worsened by Corticosteroids as an Add-On Therapy.

Medicine·2015
Same author

CUGBP1 and HuR regulate E-cadherin translation by altering recruitment of E-cadherin mRNA to processing bodies and modulate epithelial barrier function.

American journal of physiology. Cell physiology·2015
Same author

Abnormal Methylation Status of the GNAS Exon 1A Region in Pseudohypohyperparathyroidism Combined With Turner Syndrome.

The American journal of the medical sciences·2015
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Airway mucus hypersecretion in chronic bronchitis involves both submucosal glands and goblet cells. Inflammation and specific mediators, not just gland size, drive excessive mucus production.

Area of Science:

  • Respiratory physiology
  • Cell biology
  • Immunology

Background:

  • Airway mucins are primarily produced by goblet cells and submucosal glands.
  • In hypersecretory lung diseases like chronic bronchitis, asthma, and cystic fibrosis, submucosal glands are key contributors to mucus, particularly sputum.
  • Goblet cells, normally sparse in small airways, increase in hypersecretory conditions, potentially causing airflow obstruction.

Purpose of the Study:

  • To investigate the complex mechanisms underlying mucus hypersecretion in the airways.
  • To explore the role of inflammation and specific mediators in driving mucus production.
  • To identify novel cellular targets for treating mucus hypersecretion.

Main Methods:

  • Review of existing literature on airway mucus production.

Related Experiment Videos

  • Analysis of histological correlates of mucus hypersecretion.
  • Discussion of novel data linking cellular components to mucus production.

    • Main Results:

    • While increased gland mass is associated with chronic bronchitis, sputum production correlates better with airway wall inflammation.
    • Inflammatory cell secretions, mediators (e.g., interleukin-4, -13), and arachidonic acid metabolites (e.g., 15-HETE) significantly contribute to mucus hypersecretion.
    • A novel association between plasma cells and mucus hypersecretion by submucosal glands has been identified.

    Conclusions:

    • Mucus hypersecretion is a complex process influenced by multiple factors beyond just the mass of mucus-secreting tissue.
    • Inflammation and its mediators play a critical role in driving excessive mucus production.
    • Targeting inflammatory pathways and specific cell types, like plasma cells, may offer new therapeutic strategies for mucus hypersecretion.